Accretion Pharmaceuticals Ltd

NSE: ACCPL · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹185.30
Market cap: ₹206.0 Cr
Revenue (annual): ₹89.63 Cr
Net profit (annual): ₹9.67 Cr
P/E (TTM): 21.3×Sector 47.3×
Promoter holding: 73.52%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

1 Sep 2026 13:45 IST NSE

Other Announcement

Accretion Pharmaceuticals Other Announcement

Accretion Pharmaceuticals Limited approved an alteration to its Memorandum of Association to expand its business objects. The Board also approved increased borrowing and investment limits subject to shareholder approval.

Read the filing ↗